Per-Ola Attman

560 total citations
15 papers, 395 citations indexed

About

Per-Ola Attman is a scholar working on Surgery, Nephrology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Per-Ola Attman has authored 15 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 7 papers in Nephrology and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Per-Ola Attman's work include Lipoproteins and Cardiovascular Health (7 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers) and Dialysis and Renal Disease Management (5 papers). Per-Ola Attman is often cited by papers focused on Lipoproteins and Cardiovascular Health (7 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers) and Dialysis and Renal Disease Management (5 papers). Per-Ola Attman collaborates with scholars based in Sweden, United States and Netherlands. Per-Ola Attman's co-authors include Petar Alaupovic, Ola Samuelsson, James B. Moberly, Ann‐Cathrine Johansson, Carolyn Knight‐Gibson, Lars Weiss, Anders Gustafson, Susanne Ljungman, Chi‐Sun Wang and Cameron G. Knight and has published in prestigious journals such as Kidney International, Nephrology Dialysis Transplantation and Annals of Nutrition and Metabolism.

In The Last Decade

Per-Ola Attman

15 papers receiving 380 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Per-Ola Attman Sweden	10	216	206	176	53	48	15	395
Alberto Casaretto United States	7	107 0.5×	128 0.6×	122 0.7×	55 1.0×	74 1.5×	8	432
Christos Tzallas Greece	9	104 0.5×	53 0.3×	156 0.9×	34 0.6×	35 0.7×	14	343
Seema Basi United States	4	83 0.4×	120 0.6×	102 0.6×	99 1.9×	12 0.3×	7	328
Seiko Hoshino Japan	12	53 0.2×	187 0.9×	66 0.4×	51 1.0×	46 1.0×	23	395
Sanja Simić‐Ogrizović Serbia	12	84 0.4×	128 0.6×	34 0.2×	54 1.0×	50 1.0×	34	343
J. Chahin Spain	9	60 0.3×	311 1.5×	94 0.5×	62 1.2×	69 1.4×	14	445
DN O'Neal Australia	10	160 0.7×	48 0.2×	291 1.7×	151 2.8×	12 0.3×	17	436
H. Barle Sweden	12	71 0.3×	68 0.3×	79 0.4×	45 0.8×	39 0.8×	24	426
Jean Daniel Lalau France	5	54 0.3×	124 0.6×	263 1.5×	20 0.4×	21 0.4×	5	490
Jacentha Buggs United States	14	132 0.6×	115 0.6×	87 0.5×	66 1.2×	8 0.2×	42	388

Countries citing papers authored by Per-Ola Attman

Since Specialization

Citations

This map shows the geographic impact of Per-Ola Attman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Per-Ola Attman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Per-Ola Attman more than expected).

Fields of papers citing papers by Per-Ola Attman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Per-Ola Attman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Per-Ola Attman. The network helps show where Per-Ola Attman may publish in the future.

Co-authorship network of co-authors of Per-Ola Attman

This figure shows the co-authorship network connecting the top 25 collaborators of Per-Ola Attman. A scholar is included among the top collaborators of Per-Ola Attman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Per-Ola Attman. Per-Ola Attman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Attman, Per-Ola, et al.. (2023). Lifetime risk of severe kidney disease in lithium-treated patients: a retrospective study. International Journal of Bipolar Disorders. 11(1). 39–39. 4 indexed citations

Attman, Per-Ola, et al.. (2021). Should impaired renal function be considered a contra-indication for starting lithium?. Nordic Journal of Psychiatry. 75(sup1). S7–S7. 1 indexed citations

Herlitz, Hans, et al.. (2011). Lipoprotein Abnormalities in Patients with Atherosclerotic Renovascular Disease. Kidney & Blood Pressure Research. 34(5). 311–319. 3 indexed citations

Attman, Per-Ola, et al.. (2005). Prevention of clot formation during haemodialysis using the direct thrombin inhibitor melagatran in patients with chronic uraemia. Nephrology Dialysis Transplantation. 20(9). 1889–1897. 1 indexed citations

Attman, Per-Ola, Ola Samuelsson, Ann‐Cathrine Johansson, James B. Moberly, & Petar Alaupovic. (2003). Dialysis modalities and dyslipidemia. Kidney International. 63. S110–S112. 62 indexed citations

Moberly, James B., Per-Ola Attman, Ola Samuelsson, et al.. (2002). Alterations in Lipoprotein Composition in Peritoneal Dialysis Patients. Peritoneal Dialysis International. 22(2). 220–228. 28 indexed citations

Attman, Per-Ola, et al.. (2001). Do High-flux Dialysis Membranes Affect Renal Dyslipidemia?. ASAIO Journal. 47(3). 229–234. 13 indexed citations

Attman, Per-Ola, Ola Samuelsson, James B. Moberly, et al.. (1999). Apolipoprotein B-containing lipoproteins in renal failure: The relation to mode of dialysis. Kidney International. 55(4). 1536–1542. 60 indexed citations

Moberly, James B., et al.. (1999). Apolipoprotein C-III, Hypertriglyceridemia and Triglyceride-Rich Lipoproteins in Uremia. PubMed. 25(4-6). 258–262. 24 indexed citations

10.

Johnsson, Eva, Per-Ola Attman, Ola Samuelsson, & Börje Haraldsson. (1999). Improved clearance of iohexol with longer haemodialysis despite similar Kt/V for urea. Nephrology Dialysis Transplantation. 14(10). 2407–2412. 8 indexed citations

11.

Attman, Per-Ola. (1998). Progression of renal failure and lipids - is there evidence for a link in humans?. Nephrology Dialysis Transplantation. 13(3). 545–547. 10 indexed citations

12.

Attman, Per-Ola & Petar Alaupovic. (1991). Lipid and Apolipoprotein Profiles of Uremic Dyslipoproteinemia -Relation to Renal Function and Dialysis. The Nephron journals/Nephron journals. 57(4). 401–410. 142 indexed citations

13.

Attman, Per-Ola & Petar Alaupovic. (1990). Pathogenesis of Hyperlipidemia in the Nephrotic Syndrome. American Journal of Nephrology. 10(1). 69–75. 17 indexed citations

14.

Attman, Per-Ola, Anders Gustafson, Petar Alaupovic, & Chi‐Sun Wang. (1984). Effect of Protein-Reduced Diet on Plasma Lipids, Apolipoproteins and Lipolytic Activities in Patients with Chronic Renal Failure. American Journal of Nephrology. 4(2). 92–98. 11 indexed citations

15.

Attman, Per-Ola & Anders Gustafson. (1980). Lipid and Carbohydrate Metabolism in Uremia. Annals of Nutrition and Metabolism. 24(4). 261–280. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact